Evelyn Partners’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.91K Sell
105
-167
-61% -$2.96K ﹤0.01% 639
2026
Q2
$4.36K Hold
272
– – ﹤0.01% 513

Other funds holding TAK

Evelyn Partners's TAK Position: Q3 2026 in Review

Evelyn Partners reduced its Takeda Pharmaceutical (TAK) stake by 61% in Q3 2026, selling an estimated $2.96K and leaving 105 shares worth $1.91K. The position accounts for ﹤0.01% of the portfolio, ranked #639.

Evelyn Partners first reported a position in TAK in Q2 2026 and has held it in 2 quarters since. The position peaked at $4.36K in Q2 2026. 400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Evelyn Partners held 105 shares of Takeda Pharmaceutical worth $1.91K as of Q3 2026.
  • Evelyn Partners sold 167 Takeda Pharmaceutical shares in Q3 2026, an estimated $2.96K.
  • Takeda Pharmaceutical made up ﹤0.01% of Evelyn Partners's portfolio in Q3 2026, its #639 holding.
  • Evelyn Partners first reported a position in Takeda Pharmaceutical in Q2 2026 and has held it in 2 quarters since.
  • Evelyn Partners's Takeda Pharmaceutical position peaked at $4.36K in Q2 2026.
  • 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Evelyn Partners's 13F filing for Q3 2026, filed 10 Nov 2026.